Abstract P2-02-03: the collagen receptor Endo180: a metastatic plasma marker in breast cancer modulated by bisphosphonate treatment
(2012)
Journal Article
Sturge, J., Caley, M., Purshouse, K., Fonseca, A., Rodriguez-Teja, M., Kogianni, G., …Palmieri, C. (2012). Abstract P2-02-03: the collagen receptor Endo180: a metastatic plasma marker in breast cancer modulated by bisphosphonate treatment. Cancer Research, 72(24 suppl), https://doi.org/10.1158/0008-5472.sabcs12-p2-02-03
All Outputs (5)
Sphingosine kinase-1 and the collagen-binding receptor Endo180 cooperate to mediate collagen remodelling by stromal fibroblasts (2010)
Journal Article
Bruche, S., Caley, M., Pshezhetskiy, D., & Sturge, J. (2010). Sphingosine kinase-1 and the collagen-binding receptor Endo180 cooperate to mediate collagen remodelling by stromal fibroblasts. International Journal of Experimental Pathology, 91(6), A9
Macrophage-mediated breast cancer cell chemotaxis: the role of sphingosine kinase-1 activation (2010)
Journal Article
Nunes, J., Sauer, L., Turner, J., Waxman, J., Sturge, J., & Pshezhetskiy, D. (2010). Macrophage-mediated breast cancer cell chemotaxis: the role of sphingosine kinase-1 activation. Breast Cancer Research, 12(S1), S6-S6. https://doi.org/10.1186/bcr2513
Endo180 expression by tumour cells with an invasive phenotype correlates with prostate cancer progression (2008)
Journal Article
Kogianni, G., Walker, M., Waxman, J., & Sturge, J. (2008). Endo180 expression by tumour cells with an invasive phenotype correlates with prostate cancer progression. EJC Supplements, 6(9), 79. https://doi.org/10.1016/s1359-6349%2808%2971480-0
OC6. Endo180 function in metastatic prostate cancer bone lesions (2008)
Journal Article
Kogianni, G., Eleftheriou, K., Waxman, J., Cobb, J. P., & Sturge, J. (2008). OC6. Endo180 function in metastatic prostate cancer bone lesions. Cancer Treatment Reviews, 34(Suppl 1), 51. https://doi.org/10.1016/j.ctrv.2008.03.032